Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 16;18(1):208.
doi: 10.1186/s13018-023-03694-9.

Active surveillance of atypical cartilaginous tumours of bone: short term quality of life measurements

Claudia Deckers  1 , Nander T van Zeijl  2 , Miranda L van Hooff  2 , Petra I Veldman-Goossen  2 , H W Bart Schreuder  2 , Edwin F Dierselhuis  2 , Ingrid C M van der Geest  2
Affiliations

Active surveillance of atypical cartilaginous tumours of bone: short term quality of life measurements

Claudia Deckers et al. J Orthop Surg Res. .

Abstract

Background: In the recent years active surveillance has been introduced for atypical cartilaginous tumours (ACT). This is the first study on the impact of this new treatment approach on patients' quality-of-life. We evaluated general health-related quality of life (HRQL) in patients diagnosed with enchondroma or ACT.

Methods: In this prospective study, patients recently diagnosed with enchondroma and ACT of the long bones were asked to participate. Health-related quality of life (HRQL) was assessed at diagnosis and at six month follow-up, using the 36-item Short Form Health Survey (SF-36) and Numeric Pain Rating Scale (NRS). HRQL of the active surveillance group was compared to the Dutch population and a Dutch sample with locoregional cancer.

Results: In total, 45 patients were included in the study, of which four patients underwent curettage and cryosurgery, 41 patients were under active surveillance. The HRQL of the active surveillance group seemed lower compared to the Dutch population, but similar to patients suffering locoregional cancers. No comparison between the surgery and the active surveillance group could be made. In the active surveillance group no statistical difference was found between baseline and six months follow-up regarding HRQL and pain during rest and activities.

Conclusion: Patients diagnosed with non-malignant chondroid tumours have lower HRQL compared to the healthy population. Active surveillance had no adverse effect on patients well-being, after six months active surveillance the HRQL remained unchanged. Interestingly, in our study no impact on mental health was seen, implicating that diagnosed but untreated chondroid tumours do not seem to influence patients anxiety.

Keywords: Bone neoplasms; Chondrosarcoma; Quality of life; Watchful waiting.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Comparison of SF-36 subscales. Active surveillance group (n = 41) at baseline and follow-up compared to Dutch population (NL, n = 1742), Dutch population suffering local regional cancer (LRC, n = 286). Bars reflect mean SF-36 scores and standard error of the mean (SE). PF Physical function, RP Role limitations due to physical, and RE Emotional problems, VT Vitality, MH Mental health, SF Social functioning, BP Body pain, GH General health
See this image and copyright information in PMC

References

    1. Bovée JVMG, Bloem JL, Flanagan AM, Nielsen GP, Yoshida A: WHO classification of tumours editorial board. Soft tissue and bone tumours. Lyon (France): International agency for research on cancer; 2020.
    1. van Praag V, Rueten-Budde A, Ho V, Dijkstra P, van der Geest IC, Bramer JA, Schaap GR, Jutte PC, Schreuder HB, Ploegmakers J. Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas. Surg Oncol. 2018;27(3):402–408. doi: 10.1016/j.suronc.2018.05.009. - DOI - PubMed
    1. Davies AM, Patel A, Botchu R, Azzopardi C, James S, Jeys L. The changing face of central chondrosarcoma of bone. One UK-based orthopaedic oncology unit’s experience of 33 years referrals. J Clinic Orthopaedics Trauma. 2021;17:106–111. doi: 10.1016/j.jcot.2021.02.017. - DOI - PMC - PubMed
    1. Dierselhuis EF, Goulding KA, Stevens M, Jutte PC. Intralesional treatment versus wide resection for central low‐grade chondrosarcoma of the long bones. Cochrane Database Syst Rev. 2019;3(3):CD010778. 10.1002/14651858.CD010778.pub2. - PMC - PubMed
    1. Shemesh S, Acevedo-Nieves J, Pretell-Mazzini J. Treatment strategies for central low-grade chondrosarcoma of long bones: a systematic review of the literature and meta-analysis. Musculoskelet Surg. 2018;102(2):95–109. doi: 10.1007/s12306-017-0507-7. - DOI - PubMed

LinkOut - more resources